BMY Bristol-Myers Squibb
- Official Name: BRISTOL-MYERS SQUIBB CO
- Headquarters: Route 206 And Province Line Road, PRINCETON, NJ, 08543 US
- CEO: Christopher S. Boerner
- Website: bms.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-14 | 1 | Won by 3.518 | 0.935 - (2.583) | ||
| 2025-07-15 | 1R | Won by 1.377 | (1.410) - (2.787) | ||
| 2025-07-21 | 2 | Lost by 6.952 | (0.271) - 6.681 | ||
| 2025-07-23 | 1R | Lost by 2.971 | 1.577 - 4.548 | ||
| 2025-07-28 | 3 | Won by 2.485 | 2.169 - (0.316) | ||
| 2025-07-29 | 2R | Lost by 6.258 | (3.655) - 2.603 | ||
| 2025-08-04 | 4 | Won by 1.256 | (2.888) - (4.144) | ||
| 2025-08-07 | 1R | Won by 0.590 | 1.610 - 1.020 | ||
| 2025-08-11 | 5 | Won by 2.906 | 2.191 - (0.715) | ||
| 2025-08-18 | 6 | Won by 3.580 | 4.581 - 1.001 | ||
| 2025-08-21 | 2R | Won by 2.213 | 0.522 - (1.691) | ||
| 2025-08-25 | 7 | Lost by 7.313 | (3.043) - 4.270 | ||
| 2025-09-01 | 8 | Won by 0.001 | 0.115 - 0.114 | ||
| 2025-09-04 | 3R | Lost by 5.040 | (1.732) - 3.308 | ||
| 2025-09-08 | 9 | Lost by 2.939 | (1.084) - 1.855 | ||
| 2025-09-15 | 10 | Won by 3.970 | (0.840) - (4.810) | ||
| 2025-09-22 | 11 | Lost by 2.547 | (2.603) - (0.056) | ||
| 2025-09-29 | 12 | Lost by 0.177 | (1.649) - (1.472) | ||
| 2025-10-06 | 13 | Won by 6.147 | 1.608 - (4.539) | ||
| 2025-10-13 | 14 | Won by 0.803 | (3.306) - (4.109) | ||
| 2025-10-20 | 15 | Lost by 2.707 | 0.119 - 2.826 |
Latest News
SeekingAlpha - 2026-08-31
Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know
SeekingAlpha - 2026-08-31
Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs
Big Pharma hits new 52-week highs on strong Q2 results; explore why some lag and which healthcare ETF offers best income risk/reward. Click for more a...
Benzinga - 2026-08-30
Reported Earlier, Bristol Myers Reports Long-Term Camzyos Data Supporting Continued Use In Obstructive HCM
Bristol Myers Squibb (NYSE:BMY) today presented results from the EXPLORER-LTE cohort of the MAVA-LTE study (NCT03723655) in a late-breaker presentatio...
SeekingAlpha - 2026-08-28
BioNTech: Reiterating Strong Buy Based On COMIRNATY Variant Expansion And More
BioNTech SE maintains a Strong Buy rating, driven by robust late-stage oncology pipeline momentum and strategic partnerships. Click for more on BNTX.
Show more
SeekingAlpha - 2026-08-27
GSK: Still One Of My Top Healthcare Picks
SeekingAlpha - 2026-08-26
TG Therapeutics: Briumvi's Peak May Be Far Away (Rating Upgrade)
Benzinga - 2026-08-25
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
SeekingAlpha - 2026-08-24
Sanofi: Trump's Vaccine Policy Won't Break The Story
SeekingAlpha - 2026-08-22
Buy 4 Barron's Better Bets (Than T-Bills) Out Of 11 'Safer' August DiviDogs
Yahoo - 2026-08-21
Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK
Yahoo - 2026-08-21
Most Of What Moves AbbVie Stock Has Nothing To Do With The Market
Yahoo - 2026-08-21
Can Eliquis Cushion Bristol Myers' Legacy Portfolio Erosion?
Yahoo - 2026-08-21
JANX Shares Gain 19.1% in 3 Months: Here's What You Need to Know
Yahoo - 2026-08-21
Shareholder pressures Capricor; Lilly dives deeper into vaccines
Yahoo - 2026-08-20
Merck Stock Ran On A Checklist Published In Advance
Yahoo - 2026-08-20
Pfizer Stock Is A Race Between New Drugs And Old Patents
Yahoo - 2026-08-20
Can NBIX's Q2 Beat and Higher Ingrezza Guidance Drive More Growth?
Yahoo - 2026-08-20
Is NBIX Stock a Buy as Fast Growth Meets a Premium Sales Valuation?
Yahoo - 2026-08-20
Chai Discovery Announces Collaboration with Bristol Myers Squibb to Advance AI-Driven Antibody Discovery
Yahoo - 2026-08-20
Turn Bristol-Myers Squibb into an Income Machine with This Options Play
Yahoo - 2026-08-20
Why Is Merck Stock Still Undervalued After An 80% Surge?
SeekingAlpha - 2026-08-20
Tempus AI Just Had Their Entire Strategy Validated By Moderna's Vaccine Advance
Yahoo - 2026-08-19
Is AbbVie Stock About To Break Out Again?
Yahoo - 2026-08-19
Cytokinetics Gains 20.5% YTD: Buy, Sell or Hold the Stock?
Yahoo - 2026-08-19
Hematogenix's MM MRD Assay Underpins FDA Accelerated Approval of Bristol Myers Squibb's ZENBEXUS™, the First Approved CELMoD Therapy for Multiple Myeloma
SeekingAlpha - 2026-08-19
AstraZeneca Vs. Bristol-Myers Squibb: Who's The Better Bargain For Investors?
SeekingAlpha - 2026-08-17
5 Undervalued Winners Up To 6.8% And 15 Overvalued To Avoid Now
SeekingAlpha - 2026-08-14
Adicet Bio: A Cheap Gamma Delta T-Cell Play
Benzinga - 2026-08-14
Bristol Myers Squibb Gets FDA Nod For Novel Multiple Myeloma Treatment
Yahoo - 2026-08-13
Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?
Yahoo - 2026-08-13
Atrium Therapeutics Reports Second Quarter 2026 Financial Results
Yahoo - 2026-08-13
Appeals court revives $6.7B lawsuit against Bristol Myers Squibb
Benzinga - 2026-08-13
Bristol-Myers Squibb Receives FDA Approval For ZENBEXUS In Combination With Daratumumab And Hyaluronidase-fihj and Dexamethasone For Patients with Multiple Myeloma
Yahoo - 2026-08-13
The Sharpest Exchanges From ABBV's Earnings Call
Yahoo - 2026-08-13
Can Keytruda Sustain Merck's Growth in the Second Half of 2026?
Yahoo - 2026-08-13
Priori Expands Client Advisory Board with New Members from Fortune 500 Corporate Legal Departments
Yahoo - 2026-08-13
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
Benzinga - 2026-08-13
Vinod Khosla Says AI Is Creating a ‘Hyperabundance’ of New Drugs, but Testing Is Still ‘18th-Century’
Benzinga - 2026-08-12
Big Pharma's Future Growth Rests on Chinese Science? Expert Says: 'We Can't Ban Our Way Out of This'
Yahoo - 2026-08-12
How ABBV Stock Moved Away From Its Peer Group
Yahoo - 2026-08-12
Amgen Stock And The Price Of A Promise
Yahoo - 2026-08-12
Is BMY's Growth Portfolio Strong Enough to Offset Legacy Drug Declines?
Yahoo - 2026-08-12
Is Bristol Myers’ US$2.3 Billion Houston Manufacturing Campus Altering The Investment Case For BMY?
Yahoo - 2026-08-12
Will Pfizer's Non-COVID Portfolio Drive Its Next Phase of Growth?
Yahoo - 2026-08-12
Why Revolution Medicines May Be Big Pharma’s Next Takeover Target
Yahoo - 2026-08-12
How AstraZeneca’s $400bn deal unravelled
Yahoo - 2026-08-11
1 Profitable Stock with Impressive Fundamentals and 2 We Avoid
Yahoo - 2026-08-11
$49 Billion In Payouts, A Lagging Stock: The PFE Trade-Off
Yahoo - 2026-08-11
AstraZeneca PLC (AZN) vs. Bristol-Myers Squibb Company (BMY): Wall Street Doesn’t Buy This Merger Talk
SeekingAlpha - 2026-08-11
Prime Medicine: An Initial Prognosis
Yahoo - 2026-08-11
BMS Plans $2.3B Houston Manufacturing Campus
Yahoo - 2026-08-11
BMS banks on Texas for $2.3bn multi-modal manufacturing facility
SeekingAlpha - 2026-08-11
Rotation Away From Tech Lifts Moat Index In July
Yahoo - 2026-08-11
Jim Cramer Recommends Goldman Sachs and Morgan Stanley to Profit From Accelerating M&A Deals
Yahoo - 2026-08-10
Pharmaceutical giant to build $2.3B plant, create 500 jobs in Texas
Yahoo - 2026-08-10
Bristol Myers Squibb to build $2.3B advanced manufacturing plant in Houston, creating 500 jobs
Yahoo - 2026-08-10
Bristol Myers Squibb to build $2.3 billion Houston campus
Yahoo - 2026-08-10
IMCR Jumps 21.2% in 3 Months as Kimmtrak Growth Fuels More Momentum
Yahoo - 2026-08-10
Is IMCR Worth Buying as Kimmtrak Growth Meets a Premium Valuation?
Yahoo - 2026-08-10
IMCR Q2 Revenues Climb 18.3% as Kimmtrak Demand Helps Offset EPS Miss
Yahoo - 2026-08-10
Houston wins $2.3B manufacturing campus from pharma giant
Yahoo - 2026-08-10
BMY Rallies 16.2% in Three Months: Buy, Sell or Hold the Stock?
Yahoo - 2026-08-10
Bristol Myers Squibb plans $2.3 billion Houston manufacturing campus
Yahoo - 2026-08-10
Here's Why Replimune Stock Skyrockets Nearly 223% in 3 Months
Yahoo - 2026-08-10
Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas
Yahoo - 2026-08-10
Interest Rates Could Still Rise in September: 5 High-Yield Passive Income Stocks Will Benefit
Benzinga - 2026-08-10
Bristol Myers Squibb To Invest $2.3B In Houston Manufacturing Campus, Creating Nearly 500 Jobs
Yahoo - 2026-08-07
Xenon Pharmaceuticals Q2 Earnings Call Highlights
Yahoo - 2026-08-07
CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong
Yahoo - 2026-08-07
PRTA's Q2 Loss Narrower Than Expected, Pipeline Progress in Focus
Yahoo - 2026-08-07
Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling.
Yahoo - 2026-08-07
AstraZeneca (LSE:AZN) Merger Talk Fades, Is The Stock Undervalued?
Yahoo - 2026-08-07
Why Big Pharma is chasing the industry’s most-powerful supercomputer
Benzinga - 2026-08-07
Two Rejections, Messy Process: Replimune Finally Secures FDA Approval for Skin Cancer Treatment
Yahoo - 2026-08-07
These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks
Yahoo - 2026-08-07
How the FTSE became a ‘departure lounge’ for British companies
Yahoo - 2026-08-06
RVMD Posts Wider-Than-Anticipated Loss in Q2, Lifts '26 Expense View
Yahoo - 2026-08-06
Bristol Myers (BMY) Moves to Buy: Rationale Behind the Upgrade
Yahoo - 2026-08-06
EDIT Q2 Earnings Beat Estimates, Revenues Rise, Pipeline in Focus
Fintel - 2026-08-06
Argus Research Upgrades Bristol-Myers Squibb (BMY)
Yahoo - 2026-08-06
The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight
Yahoo - 2026-08-06
Schrödinger and BMS expand partnership to deploy AI for drug discovery
Yahoo - 2026-08-06
What the AstraZeneca-BMS rumors reveal about pharma megamergers
Yahoo - 2026-08-06
Schrödinger (SDGR) Is Up 8.5% After AI Co‑Scientist Deal With BMS And Q2 Profitability Shift – Has The Bull Case Changed?
CNBC - 2026-08-06
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale
Yahoo - 2026-08-06
Schrodinger Q2 Earnings Call Highlights
Yahoo - 2026-08-05
Why PFE Stock Hands You So Much Cash Right Now
Yahoo - 2026-08-05
Cardiac drug developer Braveheart banks more than $382M in IPO
Yahoo - 2026-08-05
Sector Update: Healthcare Stocks Rise Late Afternoon
Yahoo - 2026-08-05
Sector Update: Healthcare Stocks Advance Wednesday Afternoon
Yahoo - 2026-08-05
AstraZeneca-Bristol Myers’ $400B Merger Buzz Cools After Report Denies Talks – ‘There Never Was A Deal To Be Done’
SeekingAlpha - 2026-08-05
Teva Pharmaceuticals: Continuing To Execute On Its 'Pivot To Growth' Plan
Yahoo - 2026-08-05
European Stocks Close Mostly Higher in Wednesday Trading as Investors Monitor Middle East Developments
Yahoo - 2026-08-05
Prediction: AbbVie Will End The Year at This Price
Yahoo - 2026-08-05
AstraZeneca and Bristol Myers Squibb merger talks denied
Yahoo - 2026-08-05
AZN spikes 6% after report it denies AstraZeneca-BMS merger talks
SeekingAlpha - 2026-08-05
Wall Street Lunch: Parks, Pixar Power Disney
Yahoo - 2026-08-05
Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery
Yahoo - 2026-08-05
Elon Musk Has Lost the Midas Touch as AI Spending Booms
Benzinga - 2026-08-05
Argus Research Upgrades Bristol-Myers Squibb to Buy, Announces $75 Price Target
Yahoo - 2026-08-04
AstraZeneca-BMY megadeal talk sparks huge market rift
Yahoo - 2026-08-04
AstraZeneca Faces Fresh Pressure As $400B Bristol Myers Deal Talks Reportedly Persist
Yahoo - 2026-08-04
AstraZeneca could be Britain’s next loss
Yahoo - 2026-08-04
PFE Q2 Earnings Top, 2026 Sales View Tweaked, COVID Forecast Cut
Yahoo - 2026-08-04
BMY or AMGN: Which Is the Better Value Stock Right Now?
Yahoo - 2026-08-04
Bristol Myers Squibb Potential Deal With AstraZeneca Seen Unlikely as Shareholder Views Diverge, RBC Says
Yahoo - 2026-08-04
Brokers split on AstraZeneca merger talk as shares recover some ground
Yahoo - 2026-08-04
BioNTech Q2 Earnings Call Highlights
Yahoo - 2026-08-04
Are Investors Undervaluing Bristol Myers Squibb (BMY) Right Now?
Yahoo - 2026-08-04
AstraZeneca-Bristol Myers: The Floodgates for Biotech Mergers Are Open
Yahoo - 2026-08-04
How a pharma megamerger could squelch R&D
Yahoo - 2026-08-04
More Biotech M&A Is Coming, Whether an AstraZeneca-Bristol Myers Deal Happens or Not
Yahoo - 2026-08-04
‘Huh?’ Markets React to AstraZeneca’s Megadeal Talks With Bristol Myers
Yahoo - 2026-08-03
Why Did AMZN, SNOW, BMY Stocks Surge To 52-Week Highs Today?
Yahoo - 2026-08-03
Bristol-Myers Squibb (BMY) Q2 2026 Earnings Call Transcript
Yahoo - 2026-08-03
$49 Billion In Payouts, A Lagging Stock: The Pfizer Trade-Off
Yahoo - 2026-08-03
MRNA, LNTH, BMY, CAPR, RARE Stocks In Focus — These FDA Decisions Could Shape August Trading
Yahoo - 2026-08-03
AbbVie's Growth Now Leans On A Single Molecule
Yahoo - 2026-08-03
The $400 Billion Reason Bristol-Myers Squibb (BMY) Stock Is Up Today
Yahoo - 2026-08-03
Amazon, Apple, Boeing, Micron, Bristol Myers, GameStop, SpaceX, and More Stocks That Explain Today’s Market
Yahoo - 2026-08-03
AstraZeneca Stock Plunges 7.7% on Reported $400 Billion Merger Talks
Yahoo - 2026-08-03
Update: US Equity Indexes Rise Amid Rally in Communication Services; Crude Oil Slides With Treasury Yields
Yahoo - 2026-08-03
Are These 5 Pharma Stocks Set to Surpass Q2 Earnings Forecasts?
Yahoo - 2026-08-03
AstraZeneca Eyes a Pharma Megamerger Nobody Asked For
Yahoo - 2026-08-03
Top Healthcare Analyst: A $400 Billion AstraZeneca-Bristol Myers Deal Could “Cut Costs in a Big Way”
CNBC - 2026-08-03
Goldman Sachs's Hader on why AstraZeneca's stock fell on news of possible merger with Bristol Myers
Yahoo - 2026-08-03
AstraZeneca Investors See Little Logic in Bristol Tie-Up
Yahoo - 2026-08-03
Amazon, Apple, Micron, Bristol Myers, GameStop, Corning, SpaceX, and More Stocks That Explain Today’s Market
Yahoo - 2026-08-03
Stocks mixed as AstraZeneca merger talk dents FTSE 100
Yahoo - 2026-08-03
AstraZeneca shares slump after $400bn BMS merger rumours
Yahoo - 2026-08-03
AstraZeneca Nosedives On A Rumored Megamerger; Is $160 Billion Enough?
Yahoo - 2026-08-03
Top Midday Stories: Amazon Market Cap Hits $3 Trillion; AstraZeneca, Bristol Myers Squibb Reportedly Discuss $400 Billion Combination
Yahoo - 2026-08-03
European Stocks Close Mostly Higher in Monday Trading; AstraZeneca Reportedly in Merger Talks With Bristol Myers
Benzinga - 2026-08-03
Citigroup Maintains Neutral on Bristol-Myers Squibb, Raises Price Target to $70
Yahoo - 2026-08-03
4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates
Yahoo - 2026-08-03
Dementia-related Psychosis Market Gearing Up for Outstanding Expansion at a CAGR of 26.2% During the Forecast Period (2026-2036) | DelveInsight
Yahoo - 2026-08-03
AstraZeneca Stock Nosedives On Mega-Merger Rumor
Benzinga - 2026-08-03
AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus
CNBC - 2026-08-03
AstraZeneca–Bristol Myers Squibb merger 'is not highly likely to happen,' says UBS' Michael Yee
Yahoo - 2026-08-03
Medicus Pharma CMO to lead Antev's Teverelix clinical programme
Yahoo - 2026-08-03
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Amid US-Iran Truce Hopes
Benzinga - 2026-08-03
Oil Sinks 6%, Nasdaq 100 Rallies On Iran Talks: Stock Market Today
Yahoo - 2026-08-03
Update: Middle East Diplomacy Optimism, Oil Price Decline Lift US Equity Futures Pre-Bell
Benzinga - 2026-08-03
Yen Intervention And Falling Oil Help Stocks, But Selling In Korea Throws A Monkey Wrench
ChartMill - 2026-08-03
Which S&P500 stocks are moving before the opening bell on Monday?
Yahoo - 2026-08-03
AstraZeneca, Bristol Myers Squibb exploring merger talks
Yahoo - 2026-08-03
Bristol Myers Squibb Stock Jumps on Report of $400 Billion Merger Talks With Big Rival
Yahoo - 2026-08-03
An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.
Yahoo - 2026-08-03
AstraZeneca Weighs a Deal Its CEO Said It Didn't Need
Yahoo - 2026-08-03
5 Things to Know Before the Stock Market Opens on Monday
Yahoo - 2026-08-03
Stocks Rise Pre-Bell as Trump Calls Off Planned Iran Strikes; Labor Market Data, Corporate Earnings on Deck
SeekingAlpha - 2026-08-03
AstraZeneca, Bristol Myers Squibb To Merge? Let's Consider The Pros And Cons
Yahoo - 2026-08-03
Morgan Stanley uncovers major Bristol Myers stock signals
Yahoo - 2026-08-03
Analysts baffled by AstraZeneca's interest in Bristol Myers Squibb
Yahoo - 2026-08-03
Ratio Therapeutics secures $70m Series C funding for cancer radiotherapy
Yahoo - 2026-08-03
AstraZeneca in talks over £300bn mega-merger with US rival – reports
Benzinga - 2026-08-03
Why Is Bristol-Myers Squibb Stock Surging Monday?
Benzinga - 2026-08-03
Jim Cramer Senses a 'Fake Out' in Rumored AstraZeneca, Bristol Myers Squibb $400 Billion Mega-Merger
Yahoo - 2026-08-03
Bristol Myers Squibb (BMY) In Early Merger Talks With AstraZeneca
Benzinga - 2026-08-03
AstraZeneca, GameStop, Snap And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
CNBC - 2026-08-03
Stocks making the biggest moves premarket: Alibaba, Bristol-Myers Squibb, eBay & more
Yahoo - 2026-08-03
AstraZeneca shares slide 7% on talks to buy Bristol Myers Squibb
Yahoo - 2026-08-03
FTSE 100 Live: London lagging as AstraZeneca offsets gains from oil drop
SeekingAlpha - 2026-08-03
Wall Street Breakfast Podcast: Say Hello To Qwen3.8-Max
Benzinga - 2026-08-03
Why Atkore Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
CNBC - 2026-08-02
AstraZeneca slides after reports of Bristol Myers merger talks leave analysts 'perplexed'
Yahoo - 2026-08-02
Biotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure?
Yahoo - 2026-08-02
AstraZeneca plots £300bn tie-up with US rival
Benzinga - 2026-08-02
AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger
CNBC - 2026-08-02
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
Yahoo - 2026-08-01
Bristol Myers Squibb Isn't Nearly as Cheap as It Looks -- Here's the 1 Thing That Could Change That
Yahoo - 2026-08-01
Bristol Myers Squibb Q2 Earnings Call Highlights
SeekingAlpha - 2026-07-31
BioNTech: The Market Is Offering A 17-Program Oncology Pipeline For Almost Free
Yahoo - 2026-07-31
Activist Investors Shift Back to Basics: ICR Global Head of Governance Gabriel Hasson, Live at NYSE
Yahoo - 2026-07-31
AbbVie Trims Full-Year Profit Outlook Due to Apogee Acquisition
Benzinga - 2026-07-31
RBC Capital Maintains Sector Perform on Bristol-Myers Squibb, Raises Price Target to $64
Yahoo - 2026-07-31
BMY Q2 Earnings Call Highlights Growth Portfolio Momentum
Yahoo - 2026-07-31
Company News for July 31, 2026
Benzinga - 2026-07-31
JP Morgan Maintains Overweight on Bristol-Myers Squibb, Raises Price Target to $73
Yahoo - 2026-07-31
Sanofi to ‘rebuild trust’ with Regeneron; Apnimed adds to string of ‘upsized’ biotech IPOs
Benzinga - 2026-07-31
Cantor Fitzgerald Maintains Neutral on Bristol-Myers Squibb, Raises Price Target to $59
Benzinga - 2026-07-31
Wells Fargo Maintains Equal-Weight on Bristol-Myers Squibb, Raises Price Target to $65
Benzinga - 2026-07-31
Replimune Skin Cancer Therapy Hopes Revive After Positive FDA Panel Vote
Benzinga - 2026-07-31
Guggenheim Maintains Buy on Bristol-Myers Squibb, Raises Price Target to $75
Yahoo - 2026-07-31
Bristol Myers Squibb (BMY) Earnings Beat And Higher Outlook Put Valuation Back In Focus
Benzinga - 2026-07-31
Truist Securities Reiterates Buy on Bristol-Myers Squibb
Yahoo - 2026-07-30
Bristol-Myers Squibb Company Q2 2026 Earnings Call Summary
Yahoo - 2026-07-30
Why Bristol Myers Squibb Stock Topped the Market on Thursday
Yahoo - 2026-07-30
Bristol-Myers Squibb Co (BMY) (Q2 2026) Earnings Call Highlights: Growth Portfolio Surges 14%, ...
SeekingAlpha - 2026-07-30
Bristol-Myers Squibb Company (BMY) Q2 2026 Earnings Call Transcript
Benzinga - 2026-07-30
Bristol-Myers Boosts 2026 Guidance on Portfolio Strength
Yahoo - 2026-07-30
Bristol-Myers Squibb (NYSE:BMY) Reports Bullish Q2 CY2026, Guides for Strong Full-Year Sales
SeekingAlpha - 2026-07-30
Bristol-Myers Squibb Company 2026 Q2 - Results - Earnings Call Presentation
Yahoo - 2026-07-30
Bristol Myers Squibb Lifts Full-Year Guidance After Strong Second-Quarter Earnings Beat
SeekingAlpha - 2026-07-30
Replimune: 'Sell' Continued Doubt On Single-Arm IGNYTE Trial For RP1 FDA Review
Yahoo - 2026-07-30
Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Beat Estimates
SeekingAlpha - 2026-07-30
Bristol Myers Squibb: Upgrading To Buy On Positive Q2 Earnings, Long-Term Outlook
ChartMill - 2026-07-30
Bristol-Myers Squibb (NYSE:BMY) Surges on Q2 Earnings Beat, Raises Full-Year Guidance
Yahoo - 2026-07-30
Bristol Myers Squibb raises 2026 forecast after Q2 earnings beat
Benzinga - 2026-07-30
Gold Surges 3%; Bristol-Myers Squibb Earnings Top Views
Yahoo - 2026-07-30
Bristol Myers Squibb Reports Second Quarter Financial Results for 2026
SeekingAlpha - 2026-07-30
Bristol-Myers Squibb: Why I'm Still Bullish After Q2
Yahoo - 2026-07-30
How Telix landed a $2.1 billion radiopharma deal with Regeneron
CNBC - 2026-07-30
Stocks making the biggest moves premarket: Meta, Microsoft, Teladoc, Norwegian Cruise Line & more
Benzinga - 2026-07-30
Bristol-Myers Squibb Raises FY2026 Adj EPS Guidance from $6.05-$6.35 to $6.75-$7.00 vs $6.34 Est; Raises FY2026 Sales Guidance from $46.000B-$47.500B to $49.000B-$50.000B vs $47.472B Est
Benzinga - 2026-07-29
Dow Records Worst Session Since April 2025; Investor Sentiment Weakens, Greed Index Remains In ‘Fear’ Zone
Benzinga - 2026-07-29
Apple, Microsoft And 3 Stocks To Watch Heading Into Thursday
Yahoo - 2026-07-29
The Real Price of AbbVie Stock Is Cheaper Than You Think
Yahoo - 2026-07-29
Bristol Myers Squibb (BMY) Stock May Be 48% Below Fair Value On Fresh AI Drug Discovery News
Benzinga - 2026-07-29
Apple Could Swing $170 Billion In Value After Earnings
Yahoo - 2026-07-29
Pfizer Stock Ahead of Q2 Earnings: To Buy or Not to Buy?
Yahoo - 2026-07-29